The present invention relates to the treatment of Gastro Esophageal Reflux Disease (GERD). More specifically the present invention provides a method and an apparatus for enhancing the function of the lower esophageal sphincter to preclude the occurrence of Gastro Esophageal Reflux Disease.
Gastro Esophageal Reflux occurs when stomach acid splashes back through the lower esophageal sphincter into the esophagus. Highly acidic in nature, the stomach acid irritates the esophagus causing pain and discomfort. This discomfort manifests itself as heartburn, or in severe cases, as chest pains. A prolonged exposure to stomach acid will damage the esophagus and can contribute to other esophageal ailments such as Barrett's Esophagus.
Gastro Esophageal Reflux Disease, the repeated occurrence of gastro esophageal reflux, stems from an incompetent Lower Esophageal Sphincter (LES), one that has begun to inadequately close. No longer does the failing lower sphincter prevent stomach acid from splashing back into the esophagus as would a properly functioning lower sphincter. Instead, as digestion in the stomach progresses, the acid required to break down the stomach's contents refluxes, unrestricted by the lower esophageal sphincter, into the lower esophagus during each digestive cycle.
Both non-surgical and surgical methods of treatment are available to attempt to provide relief from the disease. Medications that diminish or even eliminate the acidic secretions in the stomach can be proscribed and administered to treat the sphincter dysfunction. While these medications may provide short term relief, they do not address the underlying problem of the malfunctioning sphincter. Surgery, another available treatment, seeks to address the underlying problem. One available surgical procedure, fundoplication, involves wrapping the fundus of the stomach around, and to, the lower esophageal sphincter in support of the sphincter. More specifically, as digestion begins to take place, gases begin to develop in the stomach. The amount and volume of gas increases as digestion progresses. Eventually, enough gas is present in the stomach to inflate and expand the fundus. Now wrapped around the esophagus, as the fundus inflates and expands it places pressure on the lower sphincter in support of the sphincter's complete closure. As the digestive cycle concludes the gases in the stomach subside and the closing pressure on the sphincter dissipates, once again allowing the sphincter to open.
Fundoplication has proven to be an effective method of treatment but not without some cost and risks. When the operation is performed, through an incision in the abdominal cavity (illustrated at 120 in
Other methods of performing a fundoplication are also known. For example, laproscopic procedures have been used to perform the operation. Here, rather than making an incision in the abdominal cavity, several surgical cannulas are inserted into the abdomen in various places. The surgery is then performed through these cannula portals by the surgeon as opposed to through a large incision in the abdominal cavity as would be utilized in a full abdominal fundoplication. Once completed, the recovery time from this process involves several days of hospital stay and a week or more of outpatient recovery time.
In another known approach, endoluminal procedures are used in conjunction with an abdominal incision to perform a fundoplication. Here, an invagination device containing several retractable needles is inserted into the mouth and down the esophagus to be used in conjunction with a manipulation and stapling device remotely inserted through an opening in the abdominal cavity. The fundoplication is performed by these devices with fasteners being employed to secure the fundus into its new position. In addition to requiring an abdominal breech, this procedure utilizes surgical staples that, due to the highly acidic nature of stomach acid, have not proven to be completely effective over time. Exposed to the stomach acid the staples can erode away thereby requiring a second identical procedure be performed. Other approaches also exist, but these too contain the same disadvantages—additional incisions, or mechanical fasteners susceptible to erosion from the stomach acid, or both.
It would, therefore, be desirable to have an apparatus and method for performing fundoplication wherein no additional incisions into the body would be required and wherein the risk of the fundus becoming dislodged due to the undermining of the integrity of the surgical fasteners would be diminished.
The present invention includes a method and apparatus for adhering tissue to one another. In an embodiment of the present invention the two tissues to be joined, for example the lower esophagus and the fundus of the stomach, are first placed adjacent to one another. Next, a first restraint is placed near the outside surface of one of the tissues and a second restraint is placed near the outside surface of the other tissue. An irritant is then placed between the two adjacent tissues. The restraints, and consequently the tissue surfaces, are then drawn together. As the touching irritated tissue surfaces heal they will become bonded to one another and their need for the mechanical fastening of the restraints, to secure them together, will be diminished.
The present apparatus and method can be used in the endoluminal treatment of Gastro Esophageal Reflux Disease.
The second anchor 210 and the third anchor 205 in
A method of practicing the instant invention will now be further described. As is evident
As shown in
After the fundus 330 sags back away from the lower esophageal wall 110, the pointed carrier 215 is pushed down, back through the lower esophageal wall 110, until the pointed tip is located in the void 500 between the outer fundal surface 320 and the outer wall 315 of the lower esophagus. As is evident from
The second anchor 210, previously saturated with a sclerosing agent, now comes in contact with the outer wall 320 of the fundus 330 and the outer wall 315 of the lower esophagus 110, irritating both surfaces, the surrounding tissue, and the sclerosis of both the esophagus and the fundus (not shown).
The third anchor 205 is then deployed. Once deployed, the third anchor 205 is maneuvered to the inside wall of the lower esophagus to push and draw the esophageal wall and the fundal wall between the three anchors.
The three anchors are pulled tightly together, primarily to support the fundus, and secondarily to promote the bonding of tissue resulting from the irritant placed on the second anchor and the collagen impregnating all three anchors. The tissue irritated by the sclerosing agent and exposed to the collagen will promote tissue ingrowth between the stomach and the esophagus. Over time the nitinol guy wire and the anchors may dissipate leaving the ingrown tissues of the stomach and esophagus to be the sole bond between the esophagus and the fundus.
Alternatively, rather than impregnating all three anchors with collagen, the anchors may instead be made from genetically engineered tissue designed to match the tissue of the patient. These anchors, made from the genetically engineered tissue, like the collagen impregnated anchors, will promote the ingrowth and bonding of the fundus and the esophagus after deployment within the body.
In another embodiment of the present invention, rather than using the second anchor to carry the irritating agent, the irritating agent can be squirted into place by the Endoscopist during the procedure. In this embodiment rather than having three anchors as shown in
As described above, a method and apparatus for curing Gastro Esophageal Reflux Disease is provided. The disclosed embodiments are illustrative of the various ways in which the present invention may be practiced. Other embodiments can be implemented by those of skill in the art without departing from the spirit and scope of the present invention.
This application is a Continuation Application of U.S. patent application Ser. No. 13/037,334, filed Feb. 28, 2011, now U.S. Pat. No. 8,628,543, which is a Continuation Application of U.S. patent application Ser. No. 10/992,232, filed Nov. 19, 2004, now U.S. Pat. No. 7,918,864, which is a Continuation Application of U.S. patent application Ser. No. 10/105,235, filed Mar. 26, 2002, now U.S. Pat. No. 6,837,894, which is a Continuation Application of U.S. patent application Ser. No. 09/432,575, filed Nov. 12, 1999, now U.S. Pat. No. 6,387,104, all of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3276448 | Kronenthal | Oct 1966 | A |
3874388 | King et al. | Apr 1975 | A |
3940935 | Richardson et al. | Mar 1976 | A |
4016721 | Richardson et al. | Apr 1977 | A |
4534350 | Golden et al. | Aug 1985 | A |
4550870 | Krumme et al. | Nov 1985 | A |
4669473 | Richards et al. | Jun 1987 | A |
4750492 | Jacobs | Jun 1988 | A |
4899744 | Fujitsuka et al. | Feb 1990 | A |
4917089 | Sideris | Apr 1990 | A |
5088979 | Filipi et al. | Feb 1992 | A |
5108420 | Marks | Apr 1992 | A |
5123914 | Cope | Jun 1992 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5203864 | Phillips | Apr 1993 | A |
5269809 | Hayhurst et al. | Dec 1993 | A |
5282827 | Kensey et al. | Feb 1994 | A |
5284488 | Sideris | Feb 1994 | A |
5382231 | Shlain | Jan 1995 | A |
5403326 | Harrison et al. | Apr 1995 | A |
5417691 | Hayhurst | May 1995 | A |
5425744 | Fagan et al. | Jun 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5470337 | Moss | Nov 1995 | A |
5480434 | Eckstein et al. | Jan 1996 | A |
5531759 | Kensey et al. | Jul 1996 | A |
5558665 | Kieturakis | Sep 1996 | A |
5571116 | Bolanos et al. | Nov 1996 | A |
5634936 | Linden et al. | Jun 1997 | A |
5676674 | Bolanos et al. | Oct 1997 | A |
5700277 | Nash et al. | Dec 1997 | A |
5709707 | Lock et al. | Jan 1998 | A |
5741297 | Simon | Apr 1998 | A |
5787897 | Kieturakis | Aug 1998 | A |
5810848 | Hayhurst | Sep 1998 | A |
5861004 | Kensey et al. | Jan 1999 | A |
5887594 | LoCicero, III | Mar 1999 | A |
5904703 | Gilson | May 1999 | A |
5916236 | Muijs Van de Moer et al. | Jun 1999 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6086600 | Kortenbach | Jul 2000 | A |
6113609 | Adams | Sep 2000 | A |
6156044 | Kammerer et al. | Dec 2000 | A |
6206907 | Marino et al. | Mar 2001 | B1 |
6387104 | Pugsley, Jr. et al. | May 2002 | B1 |
6494888 | Laufer et al. | Dec 2002 | B1 |
6663639 | Laufer et al. | Dec 2003 | B1 |
8057494 | Laufer et al. | Nov 2011 | B2 |
20040010245 | Cerier et al. | Jan 2004 | A1 |
20050033328 | Laufer et al. | Feb 2005 | A1 |
20090018558 | Laufer et al. | Jan 2009 | A1 |
Number | Date | Country |
---|---|---|
0 464 480 | Jan 1992 | EP |
0 585 476 | Mar 1994 | EP |
1560134 | Apr 1990 | SU |
WO 8809157 | Dec 1988 | WO |
WO 9310714 | Jun 1993 | WO |
WO 9922649 | May 1999 | WO |
WO 9960931 | Dec 1999 | WO |
WO 0057796 | Oct 2000 | WO |
Number | Date | Country | |
---|---|---|---|
20140094832 A1 | Apr 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13037334 | Feb 2011 | US |
Child | 14097391 | US | |
Parent | 10992232 | Nov 2004 | US |
Child | 13037334 | US | |
Parent | 10105235 | Mar 2002 | US |
Child | 10992232 | US | |
Parent | 09432575 | Nov 1999 | US |
Child | 10105235 | US |